Professor Matthias Pfisterer
Muenchenstein (Switzerland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Drug-eluting stents with biodegradable polymers: are enough data in for a final assessment?
Date: 16 February 2014
Journal: European Heart Journal
Long-term benefit–risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET
Date: 25 November 2008
Journal: European Heart Journal
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
Date: 19 July 2007
Journal: European Heart Journal
Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET): reply
Date: 2 July 2007
Journal: European Heart Journal
Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)<sup> </sup>
Date: 13 February 2007
Journal: European Heart Journal
ESC 365 is supported by
